Judson Englert
Technik-/Wissenschafts-/F&E-Leiter bei CYTEIR THERAPEUTICS, INC.
Profil
Judson Englert is currently working as the Senior VP-Clinical Research & Development at Cyteir Therapeutics, Inc. Previously, he worked as the Director-Oncology Clinical Development at Medimmune, Inc. He holds a doctorate degree from the University of Pittsburgh.
Aktive Positionen von Judson Englert
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTEIR THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.06.2020 |
Ehemalige bekannte Positionen von Judson Englert
| Unternehmen | Position | Ende |
|---|---|---|
| Medimmune, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Judson Englert
| University of Pittsburgh | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Cyteir Therapeutics, Inc.
 Cyteir Therapeutics, Inc. BiotechnologyHealth Technology Cyteir Therapeutics, Inc.is a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for combination therapy in solid tumors and hematologic malignancies. The company was founded by Kevin Mills and Timothy Romberger in June 2012 and is headquartered in Lexington, MA. | Health Technology |
| Medimmune, Inc. | Health Technology |
